Search Results - Abdel-Fatah, T.
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells by Sultana, Rebeka, Abdel-Fatah, Tarek, Perry, Christina, Moseley, Paul, Albarakti, Nada, Mohan, Vivek, Seedhouse, Claire, Chan, Stephan, Madhusudan, Srinivasan
Published 2013Get full text
-
7
Targeting ataxia telangiectasia mutated and Rad3 related kinase (ATR) in PTEN deficient breast cancers for personalized therapy by Al-Subhi, Nouf, Ali, Reem, Abdel-Fatah, Tarek, Moseley, Paul M., Chan, Stephen Y.T., Green, Andrew R., Ellis, Ian O., Rakha, Emad, Madhusudan, Srinivasan
Published 2018Get full text
-
8
Nottingham clinico-pathological response index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer by Abdel-Fatah, T., Ball, G., Lee, A., Pinder, S., MacMilan, R., Cornford, E., Moseley, P., Silverman, R., Price, J., Latham, B., Palmer, D., Chan, Arlene, Ellis, I., Chan, S.
Published 2015Get full text
-
9
Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer? by Abdel-Fatah, Tarek, Arora, Arvind, Gorguc, Ipek, Abbotts, Rachel, Beebeejaun, Sarah, Storr, Sarah J., Mohan, Vivek, Hawkes, Claire, Soomro, Irshad N., Lobo, Dileep N., Parsons, Simon L., Madhusudan, Srinivasan
Published 2013Get full text
-
10
Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers by Arora, Arvind, Parvathaneni, Swetha, Aleskandarany, Mohammed A., Agarwal, Devika, Ali, Reem, Abdel-Fatah, Tarek, Green, Andrew R., Ball, Graham R., Rakha, Emad A., Ellis, Ian O., Sharma, Sudha, Madhusudan, Srinivasan
Published 2017Get full text
-
11
Transcriptomic and protein expression analysis reveals clinicopathological significance of bloom syndrome helicase (BLM) in breast cancer by Arora, Arvind, Abdel-Fatah, Tarek, Agarwal, Devika, Doherty, Rachel, Moseley, Paul M., Aleskandarany, Mohammed A., Green, Andrew R., Ball, Graham, Alshareeda, Alaa, Rakha, Emad, Chan, Stephen Y.T., Ellis, Ian O., Madhusudan, Srinivasan
Published 2015Get full text
-
12
The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response by Barone, Giancarlo, Arora, Arvind, Ganesh, Anil, Abdel-Fatah, Tarek, Moseley, Paul, Ali, Reem, Chan, Stephen Y.T., Savva, Constantinos, Schiavone, Kristina, Carmell, Natasha, Myers, Katie N., Rakha, Emad A., Madhusudan, Srinivasan, Collis, Spencer J.
Published 2018Get full text
-
13
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis by Abdel-Fatah, Tarek M.A., Agarwal, Devika, Liu, Dong-Xu, Russell, Roslin, Rueda, Oscar M., Liu, Karen, Xu, Bing, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Rees, Robert C., Caldas, Carlos, Ellis, Ian O., Ball, Graham R., Chan, Stephen Y.T.
Published 2016Get full text
-
14
RECQL4 helicase has oncogenic potential in sporadic breast cancers by Arora, Arvind, Agarwal, Devika, Abdel-Fatah, Tarek M.A., Lu, Huiming, Croteau, Deborah L., Moseley, Paul, Aleskandarany, Mohammed A., Green, Andrew R., Ball, Graham, Rakha, Emad A., Chan, Stephen Y.T., Ellis, Ian O., Wang, Lisa L., Zhao, Yongliang, Balajee, Adayabalam S., Bohr, Vilhelm A., Madhusudan, Srinivasan
Published 2016Get full text